KRUSE BO (EVP, CFO, Secy & Treas.) sold 2.0% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $65.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/23/2021ACC: 0001104659-21-153184
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$65.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$16.36
Trade value
$65.44K
% of position
2.0%
12/22/2021
201.08K→197.08K
Total
Net shares
−4K
Net value
-$65.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2021 | S · Sale | −4K | $16.36 | $65.44K | 2.0% | 201.08K | 197.08K |
| Total | −4K | -$65.44K | ||||||
Derivative Transactions0
No derivative transactions reported